The latest closing stock price for Halozyme Therapeutics as of November 12, 2024 is 59.61.
An investor who bought $1,000 worth of Halozyme Therapeutics stock at the IPO in 2004 would have $13,026 today, roughly 13 times their original investment - a 13.40% compound annual growth rate over 21 years.
The all-time high Halozyme Therapeutics stock closing price was 64.42 on August 28, 2024.
The Halozyme Therapeutics 52-week high stock price is 65.53, which is 9.9% above the current share price.
The Halozyme Therapeutics 52-week low stock price is 33.15, which is 44.4% below the current share price.
The average Halozyme Therapeutics stock price for the last 52 weeks is 46.54.
An investor who bought $1,000 worth of Halozyme Therapeutics stock at the IPO in 2004 would have $13,026 today, roughly 13 times their original investment - a 13.40% compound annual growth rate over 21 years.
The all-time high Halozyme Therapeutics stock closing price was 64.42 on August 28, 2024.
The Halozyme Therapeutics 52-week high stock price is 65.53, which is 9.9% above the current share price.
The Halozyme Therapeutics 52-week low stock price is 33.15, which is 44.4% below the current share price.
The average Halozyme Therapeutics stock price for the last 52 weeks is 46.54.